Search results
...for Patients With Certain Rare Diseases, Pending Medicare Part D Changes | JD Supra
JD Supra· 12 hours agoThe Department of Health and Human Services, Office of Inspector General (“OIG”) recently released a favorable advisory opinion, OIG Advisory Opinion No. 24-02 (the “Opinion”) to a nonprofit ...
Wegovy & other GLP-1 drugs to get coverage under Medicare Part D
AARP· 1 day agoThe FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are ...
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
Zacks via Yahoo Finance· 3 hours agoSales of Tyvaso DPI were driven by higher volumes and increased commercialization utilization of the...
What is the Medicare Donut Hole and What Are Your Options?
Penny Hoarder via AOL· 5 days agoMedicare can feel complicated. It’s easy to get overwhelmed when sorting through pages of...
A ‘slap in the face’: Retired state workers in Maryland outraged by drug plan switch
Baltimore Sun· 1 day agoBefore receiving a heart transplant in 2020, Mark Varner avoided imagining his life too far into the...
Maryland's retirees fear mounting healthcare costs due to prescription drug plan changes
WBFF Fox45 Baltimore· 23 hours agoLike many retirees, their medicine cabinet is full, with each pill bottle containing a different...
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 1 day agoCABOMETYX Net Product Revenues: $376.4 million, including about $6 million in clinical trial sales. Gross to Net Deductions: 32.9% for Q1 2024, primarily due to higher Medicare</ ...
Savvy Senior: Recommended vaccines for Medicare recipients
Daily Press· 6 days agoMy husband and I recently turned 65 and would like to find out which vaccines are recommended and...
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B
The National Law Review· 7 days agoOn April 15, the Centers for Medicare & Medicaid Services (CMS) released a
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance· 23 hours agoEliquis represents nearly 14% of Pfizer’s Q1 revenue, and we recognize the uncertainty tied to the...